Literature DB >> 26284308

Serum nitric oxide metabolites are associated with the risk of hypertriglyceridemic-waist phenotype in women: Tehran Lipid and Glucose Study.

Zahra Bahadoran1, Parvin Mirmiran2, Asghar Ghasemi3, Fereidoun Azizi4.   

Abstract

BACKGROUND AND AIM: There are some controversial issues regarding the association of nitric oxide and obesity-related states. This study was conducted to investigate whether serum nitric oxide metabolites (NOx) could predict the occurrence of visceral lipid accumulation, defined as hypertriglyceridemic-waist (HTW) phenotype.
METHODS: We used a prospective approach for this study conducted on participants of the Tehran Lipid and Glucose Study, 2243 adult men and women were followed for a median of 6.3 years. Serum NOx concentrations were measured at baseline (2006-2008), and demographics, anthropometrics and biochemical variables were evaluated at baseline and again after a 3-year (2009-2011) and a 6-year follow-up (2012-2014). The occurrence of HTW phenotype, defined as waist circumference ≥90 cm in men and ≥85 cm in women, along with serum triglyceride levels ≥177 mg/dL, were assessed across serum NOx tertiles.
RESULTS: Mean age of participants was 41.5 ± 14.5 years at baseline and 39.4% were male. The cumulative incidence of HTW phenotype was 37.6% (33.2% in men, 40.5% in women). There was no significant association between serum NOx and the occurrence of HTW phenotype in men. After adjustment of confounding variables, risk of HTW phenotype in women, in the highest compared to the lowest tertile of serum NOx (≥30.9 vs. <19.9 μmol/L), increased by 39% (OR = 1.39, 95% CI = 1.05-1.93, P for trend = 0.053).
CONCLUSION: Serum NOx level was an independent predictor of HTW phenotype in women.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hypertriglyceridemic-waist phenotype; Nitric oxide; Nitric oxide metabolites; Population

Year:  2015        PMID: 26284308     DOI: 10.1016/j.niox.2015.08.002

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  5 in total

Review 1.  The Nitrate-Nitrite-Nitric Oxide Pathway: Findings from 20 Years of the Tehran Lipid and Glucose Study.

Authors:  Zahra Bahadoran; Parvin Mirmiran; Sajad Jeddi; Amir Abbas Momenan; Fereidoun Azizi; Asghar Ghasemi
Journal:  Int J Endocrinol Metab       Date:  2018-10-14

Review 2.  Nutrition and Cardio-Metabolic Risk Factors: Findings from 20 Years of the Tehran Lipid and Glucose Study.

Authors:  Firoozeh Hosseini-Esfahani; Somaye Hosseinpour-Niazi; Golaleh Asghari; Zahra Bahadoran; Nazanin Moslehi; Mahdieh Golzarand; Hanieh-Sadat Ejtahed; Parvin Mirmiran; Fereidoun Azizi
Journal:  Int J Endocrinol Metab       Date:  2018-10-13

3.  Habitual intake of dietary L-arginine in relation to risk of type 2 diabetes: a prospective study.

Authors:  Parvin Mirmiran; Zahra Bahadoran; Zahra Gaeini; Fereidoun Azizi
Journal:  BMC Endocr Disord       Date:  2021-05-31       Impact factor: 2.763

4.  The Association of Dietary l-Arginine Intake and Serum Nitric Oxide Metabolites in Adults: A Population-Based Study.

Authors:  Parvin Mirmiran; Zahra Bahadoran; Asghar Ghasemi; Fereidoun Azizi
Journal:  Nutrients       Date:  2016-05-20       Impact factor: 5.717

5.  Association of plasma nitrite levels with obesity and metabolic syndrome in the Old Order Amish.

Authors:  F Akram; D Fuchs; M Daue; G Nijjar; A Ryan; M E Benros; O Okusaga; E Baca-Garcia; L A Brenner; C A Lowry; K A Ryan; M Pavlovich; B D Mitchell; S Snitker; T T Postolache
Journal:  Obes Sci Pract       Date:  2018-08-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.